<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01344291</url>
  </required_header>
  <id_info>
    <org_study_id>Turmeric-01</org_study_id>
    <nct_id>NCT01344291</nct_id>
  </id_info>
  <brief_title>Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mashhad University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mashhad University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prolactinoma is the most prevalent anterior hypophysis tumor. The principal treatment for
      this disorder is Dopamine agonist drugs including bromocriptin and Cabergoline. However, 50%
      of Bromocriptin treated and 17% of Cabergoline treated patients are resistant to these drugs.
      Curcumin is the main derivative of turmeric ,an old spice which is used frequently in Indian
      and Iranian cuisine. It has been proved that curcumin can reduce mammotrope cells
      proliferation and also intracellular hormone production. The purpose of this study is to
      evaluate the effect of turmeric on prolactinoma patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum prolactin level</measure>
    <time_frame>2weeks and one month after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in LH,FSH and estradiol from baseline</measure>
    <time_frame>one month ofter treatment</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hyperprolactinoma</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Curcumin</intervention_name>
    <description>Curcumin is prescribed to new cases of hyperprolactinoma</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hyperprolactinemia

          -  microprolactinoma

        Exclusion Criteria:

          -  pregnancy

          -  macroadenoma

          -  neurologic signs due to tumor
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>haleh rokni, proffessore assisstant</last_name>
    <phone>00981082976</phone>
    <email>roknih@mums.ac.ir</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mashad University of Medical Sciences</name>
      <address>
        <city>Mashad</city>
        <state>Khorasan Razavi</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>haleh rokni</last_name>
      <phone>00985118012976</phone>
      <email>roknih@mums.ac.ir</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2011</study_first_submitted>
  <study_first_submitted_qc>April 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2011</study_first_posted>
  <last_update_submitted>October 29, 2011</last_update_submitted>
  <last_update_submitted_qc>October 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mashhad University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Haleh Rokni Yazdi</investigator_full_name>
    <investigator_title>assisstant professor</investigator_title>
  </responsible_party>
  <keyword>hyperprolactinoma</keyword>
  <keyword>turmeric</keyword>
  <keyword>amenorrhea</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

